Axon Science, Inc., is a woman-owned and operated business offering regulatory consulting services to industries regulated by the U.S. Food and Drug Administration (FDA) and international regulatory agencies.

We understand the unique challenges faced by businesses in highly regulated industries. Axon Science provides comprehensive guidance and support to ensure compliance with domestic and international dynamic regulatory requirements.

With our in-depth knowledge and experience, we help our clients navigate the complex regulatory landscape and achieve success in their respective markets by offering specialized services.

Founded and Operated by a Scientist

Axons are the primary transmission lines of the central nervous system. Our founder Cynthia M. Barber, Ph.D., named our business after axons because everything we do is based on scientifically sound principles and transmitting information on behalf of our partners to regulatory authorities.

In some ways, we believe we act as transmitters too. We offer guidance to organizations in different industries that often centers on documentation and transmission via precise communications with the FDA.

We make certain the right information is documented and communicated effectively to achieve high rates of compliance. From plant audits and research and development (R&D) to regulatory filings, we make certain organizations document and transmit required information.

Therapeutic Discovery and Federal Grant Funding

The Internal Revenue Service (IRS), in conjunction with the Department of Health and Human Services, approved Axon Science’s application for projects that showed significant potential to produce new and cost-saving therapies, support jobs, and increase U.S. competitiveness.

In 2010, Axon Science was awarded grant funding under the U.S. Government’s Qualifying Therapeutic Discovery Project (QTDP) program established under Section 48D of the Internal Revenue Code. Our grant award was related to research and development efforts addressing nutritional deficiencies with safe, therapeutic formulations sourced from bioactive compounds.